216 related articles for article (PubMed ID: 33145487)
1. Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county.
Suwabe T; Chamberlain AM; Killian JM; King BF; Gregory AV; Madsen CD; Wang X; Kline TL; Chebib FT; Hogan MC; Kamath PS; Harris PC; Torres VE
JHEP Rep; 2020 Dec; 2(6):100166. PubMed ID: 33145487
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County.
Suwabe T; Shukoor S; Chamberlain AM; Killian JM; King BF; Edwards M; Senum SR; Madsen CD; Chebib FT; Hogan MC; Cornec-Le Gall E; Harris PC; Torres VE
Clin J Am Soc Nephrol; 2020 Jan; 15(1):69-79. PubMed ID: 31791998
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.
Martin WP; Vaughan LE; Yoshida K; Takahashi N; Edwards ME; Metzger A; Senum SR; Masyuk TV; LaRusso NF; Griffin MD; El-Zoghby Z; Harris PC; Kremers WK; Nagorney DM; Kamath PS; Torres VE; Hogan MC
Mayo Clin Proc Innov Qual Outcomes; 2019 Jun; 3(2):149-159. PubMed ID: 31193902
[TBL] [Abstract][Full Text] [Related]
4. Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.
van Aerts RMM; Kievit W; de Jong ME; Ahn C; Bañales JM; Reiterová J; Nevens F; Drenth JPH
Liver Int; 2019 Mar; 39(3):575-582. PubMed ID: 30225933
[TBL] [Abstract][Full Text] [Related]
5. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
[TBL] [Abstract][Full Text] [Related]
6. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
7. Genetic Analysis of Severe Polycystic Liver Disease in Japan.
Mizuno H; Besse W; Sekine A; Long KT; Kurihara S; Oba Y; Yamanouchi M; Hasegawa E; Suwabe T; Sawa N; Ubara Y; Somlo S; Hoshino J
Kidney360; 2024 May; ():. PubMed ID: 38689396
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
[TBL] [Abstract][Full Text] [Related]
10. Association of a novel
Wang J; Yang H; Guo R; Sang X; Mao Y
Ann Transl Med; 2021 Jan; 9(2):120. PubMed ID: 33569422
[TBL] [Abstract][Full Text] [Related]
11. Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum.
Boerrigter MM; Te Morsche RHM; Venselaar H; Pastoors N; Geerts AM; Hoorens A; Drenth JPH
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628703
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
13. Polycystic liver disease genes: Practical considerations for genetic testing.
Boerrigter MM; Bongers EMHF; Lugtenberg D; Nevens F; Drenth JPH
Eur J Med Genet; 2021 Mar; 64(3):104160. PubMed ID: 33556586
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.
D'Agnolo HM; Kievit W; Takkenberg RB; Riaño I; Bujanda L; Neijenhuis MK; Brunenberg EJ; Beuers U; Banales JM; Drenth JP
J Hepatol; 2016 Sep; 65(3):601-7. PubMed ID: 27212247
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Open Fenestration for Autosomal Dominant Polycystic Liver Disease.
Norcia LF; Watanabe EM; Hasimoto CN; Pelafsky L; de Oliveira WK; Sassaki LY
Case Rep Gastroenterol; 2022; 16(1):201-208. PubMed ID: 35528778
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.
Peces R; Drenth JP; Te Morsche RH; González P; Peces C
World J Gastroenterol; 2005 Dec; 11(48):7690-3. PubMed ID: 16437702
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of autosomal dominant polycystic liver disease.
Qian Q; Li A; King BF; Kamath PS; Lager DJ; Huston J; Shub C; Davila S; Somlo S; Torres VE
Hepatology; 2003 Jan; 37(1):164-71. PubMed ID: 12500201
[TBL] [Abstract][Full Text] [Related]
18. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.
Li A; Davila S; Furu L; Qian Q; Tian X; Kamath PS; King BF; Torres VE; Somlo S
Am J Hum Genet; 2003 Mar; 72(3):691-703. PubMed ID: 12529853
[TBL] [Abstract][Full Text] [Related]
19. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
20. Center is an important indicator for choice of invasive therapy in polycystic liver disease.
D'Agnolo HM; Kievit W; van Munster KN; van der Laan JJ; Nevens F; Drenth JP
Transpl Int; 2017 Jan; 30(1):76-82. PubMed ID: 27732751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
